Skip to main content
. Author manuscript; available in PMC: 2018 Mar 5.
Published in final edited form as: Leukemia. 2016 Aug 29;31(3):625–636. doi: 10.1038/leu.2016.243

Figure 2.

Figure 2

Correlation of PRDM1 mutations with poor prognosis for DLBCL. (a) In ABC-DLBCL, patients with PRDM1 mutations had shorter OS and PFS durations than did patients with wild-type PRDM1. (b) PRDM1 mutations within exons 1 and 2 had even greater poor impact on OS and PFS compared to did the overall mutation cohort. (c) The detailed distribution of PRDM1 mutations within exons 1 and 2.